Evidence map›Paper›PMID 33014652›Full record

ReviewCureus2020

Remote Oncology Care: Review of Current Technology and Future Directions.

Bradley A McGregor, Gregory A Vidal, Sumit A Shah, James D Mitchell, Andrew E Hendifar

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. A mobile supportive care app for patients with metastatic lung cancer: the Lung Cancer App (LuCApp) randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Opportunities for Home Cancer Care: The Final Frontier.NEJM catalyst innovations in care delivery · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Common methods of determining meaningful change in clinical practice: implications for precision patient-reported outcomes.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  13. Article
  14. mHealth for Medication and Side Effect Monitoring: Patients' Attitudes Toward Smart Devices for Managing Oral Chemotherapy During Lung Cancer Treatment.International Conference on Pervasive Computing Technologies for Healthcare : [proceedings]. International Conference on Pervasive Computing Technologies for Healthcare · 2023
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Bradley A McGregorOncology, Dana-Farber Cancer Institute, Boston, USA.
Gregory A VidalOncology, West Cancer Center and Research Institute and the University of Tennessee Health Science Center, Memphis, USA.
Sumit A ShahOncology, Stanford University School of Medicine, Palo Alto, USA.
James D MitchellRadiation Oncology, Northbay Healthcare, Vacaville, USA.
Andrew E HendifarOncology, Cedars-Sinai Medical Center, Los Angeles, USA.
Palo Alto University · USDana-Farber Cancer Institute · USNorthBay Healthcare · USWest Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients frequently develop tumor and treatment-related complications, leading to diminished quality of life, shortened survival, and overutilization of emergency department and hospital services. Outpatient oncology treatment has potential to leave cancer patients unmonitored for long periods while at risk of clinical deterioration which has been exaggerated during the COVID19 pandemic. Visits to cancer clinics and hospitals risk exposing immunocompromised patients to infectious complications. Remote patient reported outcomes monitoring systems have been developed for use in cancer treatment, showing benefits in economic and survival outcomes. While advanced devices such as pulmonary artery pressure monitors and implantable loop recorders have proven benefits in cardiovascular care, similar options do not exist for oncology. Here we review the current literature around remote patient monitoring in cancer care and propose the use of reliable devices for capturing and reporting patient symptoms and physiology.

Indexed as

implantable medical deviceoncologypatient reported outcomesproremote monitoringrpm

Identifiers

PMID33014652
PMCPMC7526951
OpenAlexW3082607664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.